Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Humanwell Healthcare (Group) Co's PEG Ratio or its related term are showing as below:
SHSE:600079'
s PEG Ratio Range Over the Past 10 Years
Min: 0.27 Med: 2.19 Max: 128.2
Current: 127.9
During the past 13 years, Humanwell Healthcare (Group) Co's highest PEG Ratio was 128.20. The lowest was 0.27. And the median was 2.19.
SHSE:600079's PEG Ratio is ranked worse than 99.14% of 348
companies
in the Drug Manufacturers industry
Industry Median: 1.665
vs SHSE:600079: 127.90
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Humanwell Healthcare (Group) Co (SHSE:600079) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Humanwell Healthcare (Group) Co PEG Ratio Related Terms
Humanwell Healthcare (Group) Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humanwell Healthcare (Group) Co PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Humanwell Healthcare (Group) Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Humanwell Healthcare (Group) Co (SHSE:600079) has a PEG Ratio of 127.92 as of Jul. 14, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Humanwell Healthcare (Group) Co and its competitors. This is 5741% above median its historical median of 2.19. Over the past decade, Humanwell Healthcare (Group) Co's PEG Ratio has ranged from 0.27 to 128.20. According to the industry distribution chart, Humanwell Healthcare (Group) Co ranks #345 out of 348 companies in the Drug Manufacturers industry, placing it in the top 99.1%.
Is Humanwell Healthcare (Group) Co's PEG Ratio too high?
Humanwell Healthcare (Group) Co's current PEG Ratio of 127.92 is 5741% above median its 10-year median of 2.19. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 128.20. The Drug Manufacturers industry median PEG Ratio is 1.67. Humanwell Healthcare (Group) Co's value of 127.92 is 7582.9% above this industry median. Based on the distribution chart, Humanwell Healthcare (Group) Co ranks #345 out of 348 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Humanwell Healthcare (Group) Co ranks #345 out of 348 companies for PEG Ratio. This places Humanwell Healthcare (Group) Co in the lower half of its industry. The industry median PEG Ratio is 1.67. Humanwell Healthcare (Group) Co's value of 127.92 is 7582.9% above this benchmark. Historically, Humanwell Healthcare (Group) Co's own PEG Ratio has ranged from 0.27 to 128.20 over the past decade. While the company's 10-year median is 2.19 vs. the industry median of 1.67, Humanwell Healthcare (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.67, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humanwell Healthcare (Group) Co's current PEG Ratio of 127.92 is 7582.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Humanwell Healthcare (Group) Co and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humanwell Healthcare (Group) Co's current PEG Ratio is 127.92, which is 5741% above median its own 10-year median of 2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.63, compared to a current price of ¥17.55 — trading 18.9% below its estimated fair value. The current PEG Ratio is 127.92, which is 5741% above median its 10-year median of 2.19 and 7582.9% above the Drug Manufacturers industry median of 1.67. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current PEG Ratio is 127.92 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued.
The current stock price of ¥17.55 is trading 18.9% below its estimated GF Value™ of ¥21.63.
GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600079:
PEG Ratio: 127.92 (5741% above median its 10-year median of 2.19)
GF Value™: ¥21.63 vs. price of ¥17.55 (18.9% below fair value)
Industry Position: 7582.9% above the Drug Manufacturers median (#345 of 348)
No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humanwell Healthcare (Group) Co Business Description
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score
Get the complete analysis for SHSE:600079
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600079 has been successfully added to your 
